Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick C N van den Bergh

Showing results (21-30 of 196) with videos related to

Pageof 20
Sort By:
European Urology|February 20, 2021
Reply to Michael Froehner, Rainer Koch, and Markus Graefen's Letter to the Editor re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62. Comorbidity Measurement in Patients with Prostate CancerRoderick C N van den Bergh, Shane O'Hanlon, Philip Cornford, et al.
Current Opinion in Urology|February 24, 2012
Psychological aspects of active surveillanceRoderick C N van den Bergh, Ida J Korfage, Chris H Bangma
European Urology Open Science|September 22, 2021
TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate-RefereeRoderick C N van den Bergh, Lieke Wever, Harm H E van Melick
European Journal of Cancer (Oxford, England : 1990)|November 5, 2010
Deciding on PSA-screening - Quality of current consumer information on the InternetIda J Korfage, Roderick C N van den Bergh, Marie-Louise Essink-Bot
Nederlands Tijdschrift Voor Geneeskunde|June 2, 2026
[Screening for prostate cancer; a screening program is favored over current opportunistic testing]Roderick C N van den Bergh, Monique J Roobol, Pim J van Leeuwen
European Urology|May 10, 2016
Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the FutureRoderick C N van den Bergh, Declan G Murphy, Henk G van der Poel
BJU International|September 22, 2015
Gleason pattern 4: active surveillance no moreNiranjan J Sathianathen, Declan G Murphy, Roderick C N van den Bergh, et al.
The Journal of Urology|September 8, 2018
Editorial CommentRoderick C N van den Bergh, Henk G van der Poel, Declan G Murphy
European Urology Open Science|September 1, 2022
Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?Joris G Heetman, Lieke Wever, Leonor J Paulino Pereira, et al.
Urology|September 7, 2021
EDITORIAL COMMENTTimo F W Soeterik, Harm H E van Melick, Roderick C N van den Bergh
Pageof 20

Showing results (21-30 of 196) with videos related to

Sort By:
Pageof 20
European Urology|February 20, 2021
Reply to Michael Froehner, Rainer Koch, and Markus Graefen's Letter to the Editor re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62. Comorbidity Measurement in Patients with Prostate CancerRoderick C N van den Bergh, Shane O'Hanlon, Philip Cornford, et al.
Current Opinion in Urology|February 24, 2012
Psychological aspects of active surveillanceRoderick C N van den Bergh, Ida J Korfage, Chris H Bangma
European Urology Open Science|September 22, 2021
TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate-RefereeRoderick C N van den Bergh, Lieke Wever, Harm H E van Melick
European Journal of Cancer (Oxford, England : 1990)|November 5, 2010
Deciding on PSA-screening - Quality of current consumer information on the InternetIda J Korfage, Roderick C N van den Bergh, Marie-Louise Essink-Bot
Nederlands Tijdschrift Voor Geneeskunde|June 2, 2026
[Screening for prostate cancer; a screening program is favored over current opportunistic testing]Roderick C N van den Bergh, Monique J Roobol, Pim J van Leeuwen
European Urology|May 10, 2016
Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the FutureRoderick C N van den Bergh, Declan G Murphy, Henk G van der Poel
BJU International|September 22, 2015
Gleason pattern 4: active surveillance no moreNiranjan J Sathianathen, Declan G Murphy, Roderick C N van den Bergh, et al.
The Journal of Urology|September 8, 2018
Editorial CommentRoderick C N van den Bergh, Henk G van der Poel, Declan G Murphy
European Urology Open Science|September 1, 2022
Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?Joris G Heetman, Lieke Wever, Leonor J Paulino Pereira, et al.
Urology|September 7, 2021
EDITORIAL COMMENTTimo F W Soeterik, Harm H E van Melick, Roderick C N van den Bergh
Pageof 20